Fig. 5

A–D Graphical representation of confusion matrices obtained from PLS-DA models (metabolomics A, lipidomics B) of both independent modalities for the test phase classifying AFP-negative HCC patients. The ROC curves (metabolomics C, lipidomics D) reported compares the models’ performances reducing the number of variables to the VIPs and the first 20 VIPs